88IV - PR Newswire Asia's news


ABEC Expands Process Sciences Group to Strengthen Bioprocess Optimization Capabilities BETHLEHEM, Pa. , May 6, 2026 /PRNewswire/ -- ABEC, a global leader in bioprocess engineering solutions, announced the expansion of its Process Sciences group, expanding its ability to help biopharmaceutical ... 2026-05-06T Biotechnology Computer/Electronics Health Care/Hospital Medical/Pharmaceuticals
(E,E)-bisantrene Discovered to Function via Silencing of c-MYC Expression Preclinical studies have highlighted how (E,E)-bisantrene silences c-MYC gene expression via G4-DNA binding and stabilization leading to clinically relevant and broad anticancer activity ... 2026-05-06T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Alebund Pharmaceuticals Announces Completion of Patient Enrollment in Global Phase III Pivotal Multi-Regional Clinical Trial of AP301 for Hyperphosphatemia SHANGHAI , May 6, 2026 /PRNewswire/ -- Alebund Pharmaceuticals (Jiangsu) Limited ("Alebund" or the "Company"), an integrated biopharmaceutical company focusing on developing innovative ... 2026-05-06T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
MingMed Biotechnology Presents Positive Phase II Data of Oral QA102 for the Treatment of Intermediate Age-Related Macular Degeneration (AMD) at Association for Research in Vision and Ophthalmology (ARVO) 2026 GUANGZHOU, China , May 6, 2026 /PRNewswire/ -- MingMed Biotechnology Co., Ltd, a biomedical firm focused on the discovery and development of novel therapeutics across multiple therapeutic areas, announced ... 2026-05-06T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Samsung Biologics Listed on Dow Jones Best-in-Class World Index for Fifth Consecutive Year Marks five consecutive years of inclusion, reflecting continued progress in ESG management and execution Recognition highlights proactive alignment with evolving expectations from global stakeholders ... 2026-05-05T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Cellenkos Announces FDA Clearance of Investigational New Drug (IND) Application for Phase 1b/ 2a Trial of CK0802 in Steroid-Refractory Graft-versus-Host Disease (GVHD) Multicenter, open-label study will evaluate the safety and preliminary efficacy of CK0802, a first-in-class, off-the-shelf Treg therapy, in patients with steroid-refractory GVHD ... 2026-05-05T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
XtalPi -Enabled PharmaEngine PEP08 Achieves Enrollment Milestone, with Second Synthetic Lethality Program Underway SHENZHEN, China, May 4, 2026 /PRNewswire/ -- XtalPi (2228.HK), a leading AI- and robotics-powered innovation platform, today announced dual breakthroughs in its strategic partnership with PharmaEngine ... 2026-05-04T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Restore Vision Announces First-in-Human Clinical Interim Results for RV-001, a GPCR-Based Optogenetic Gene Therapy Phase I/II clinical trial interim results , out to 168 days, from the two RV-001 dosing cohorts with advanced Retinitis Pigmentosa are presented at key May 2026 meetings: Eyecelerator and Retinal Therapeutics ... 2026-05-01T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Formosa Pharmaceuticals and Singapore Eye Research Institute (SERI) Partner to Advance Novel Ophthalmic Formulations for Corneal Diseases SINGAPORE and TAIPEI , April 30, 2026 /PRNewswire/ -- Formosa Pharmaceuticals, Inc. ("Formosa", 6838.TW) and the Singapore Eye Research Institute ("SERI") are pleased to announce ... 2026-04-30T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
New Classification System of Malocclusions Published in the Journal of Aligner Orthodontics (JAO) by Prof. Gang Shen's Team SHANGHAI , April 30, 2026 /PRNewswire/ -- A seminal research paper titled "A New Classification System for Malocclusions with Facial Convexity" has been officially published in the 2026 Volume ... 2026-04-30T Biotechnology Health Care/Hospital Medical/Pharmaceuticals

PR Newswire Asia's news > Biotechnology